IE 11 is not supported. For an optimal experience visit our site on another browser.

Melanoma Drug Shows Promise


Researchers say the drug Keytruda has been able to extend the lives of patients with advanced melanoma. Three years after being treated, 40% of patients are still alive, compared to the usual survival rate of 5%. NBC's Erika Edwards reports.